• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6

CATEGORIES

  • 4
  • 2

PRICE

5
5
5
6

PUBLISHED

0
0
0
6

PRODUCT TYPE

6

Search "Astellas Pharma Inc. - Strategy and SWOT Report" returned 6 results.

PRODUCT TITLE
Astellas Pharma Inc. - SWOT, Strategy and Corporate Finance Report Astellas Pharma Inc. - SWOT, Strategy and Corporate Finance Report - Product Thumbnail Image

Astellas Pharma Inc. - SWOT, Strategy and Corporate Finance Report

Astellas Pharma Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product...

February 2013
FROM
Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis - Product Thumbnail Image

Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis

Synopsis 'Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business...

July 2012
FROM
Astellas Pharma Inc.: Company Profile and SWOT Analysis Astellas Pharma Inc.: Company Profile and SWOT Analysis - Product Thumbnail Image

Astellas Pharma Inc.: Company Profile and SWOT Analysis

Synopsis ICD Research's "Astellas Pharma Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview,...

September 2011
FROM
OSI Pharmaceuticals, Inc. - Strategic SWOT Analysis Review OSI Pharmaceuticals, Inc. - Strategic SWOT Analysis Review - Product Thumbnail Image

OSI Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

OSI Pharmaceuticals, Inc. - Strategic SWOT Analysis Review Summary OSI Pharmaceuticals, Inc. (OSI), a wholly owned subsidiary of Astellas US Holding, Inc., is a biopharmaceutical company. It operates...

September 2012
FROM
Regeneron Pharmaceuticals, Inc.: PharmaVitae Report Regeneron Pharmaceuticals, Inc.: PharmaVitae Report - Product Thumbnail Image

Regeneron Pharmaceuticals, Inc.: PharmaVitae Report

Analysis of Regeneron's corporate history, corporate relationships, prospects to the end of the forecast period, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses,...

May 2012
FROM
Medivation, Inc. (MDVN) - Financial and Strategic Analysis Review Medivation, Inc. (MDVN) - Financial and Strategic Analysis Review - Product Thumbnail Image

Medivation, Inc. (MDVN) - Financial and Strategic Analysis Review

Medivation, Inc. (Medivation) is a biopharmaceutical company engaged in the research and development of small molecule drugs. The company initiates drug development programs for the development of...

July 2010
FROM
Loading Indicator